What should I know about clinical trials
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Clinical Trials: A Comprehensive Guide
Clinical trials are research studies that test new treatments, drugs, or approaches to cancer care. Here's what you should know:
What [facility removed]al Trials?
Clinical trials evaluate whether new treatments are safe and effective before they become standard care. They test innovations like new drugs, drug combinations, surgical techniques, radiation methods, or prevention strategies.
According to the National Cancer Institute (NCI), clinical trials happen in phases:
- Phase I: Tests safety and dosage (20-80 participants)
- Phase II: Evaluates effectiveness and side effects (100-300 participants)
- Phase III: Compares new treatment to standard care (hundreds to thousands of participants)
- Phase IV: Monitors long-term effects after FDA approval
Key Benefits to Consider
The American Cancer Society highlights these potential advantages:
- Access to promising new treatments before they're widely available
- Close monitoring by a specialized medical team
- Contributing to cancer research that helps future patients
- Receiving cutting-edge care at no cost (investigational treatment is typically free)
Important Considerations
ASCO (American Society of Clinical Oncology) Guidelines emphasize understanding:
- Eligibility criteria: Specific requirements based on cancer type, stage, and prior treatments
- Informed consent: You'll receive detailed information about risks, benefits, and alternatives
- Randomization: Some trials randomly assign treatments; you may receive standard care instead of the experimental treatment
- Side effects: New treatments may have unknown or unexpected side effects
- Time commitment: More frequent visits and monitoring than standard care
Protections in Place
All clinical trials must be:
- Approved by an Institutional Review Board (IRB) that protects participant rights
- Registered with the FDA and monitored for safety
- Conducted with your voluntary informed consent - you can leave at any time
Finding Trials
The NCI recommends these resources:
- ClinicalTrials.gov: Comprehensive federal database
- NCI's Cancer Information Service: 1-800-4-CANCER
- Your oncologist's recommendations
- Major cancer centers often have trial coordinators
Questions to Ask Your Team
- What is the purpose of this trial?
- What are the potential risks and benefits compared to standard treatment?
- What will my participation involve (visits, tests, duration)?
- Who will oversee my care?
- What happens if the treatment doesn't work or I experience side effects?
- Will I have any costs?
Important to Remember
Clinical trials are completely voluntary. Choosing not to participate won't affect your standard care. Many patients find trials offer hope and access to innovation, while others prefer established treatments.
Your healthcare team is your best resource for discussing whether a specific trial matches your situation, values, and treatment goals.
Would you like help finding trials for a specific cancer type, or do you have questions about a particular trial you're considering?
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Related Services
Services that may help with clinical trials for cancer patients
Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...
TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...
TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya
It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...
TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2